AstraZeneca PLC AstraZeneca is strengthening its portfolio with GLP-1 targeted drugs and actively engaging in clinical trials for obesity-related metabolic conditions
[17] Actimed Therapeutics
At 4-6g of Fibersol with each meal, clinical studies have shown that Fibersol: In addition to the beneficial effects on GLP-1, satiety and blood sugar, Fibersol provides other positive wellness impacts: The satiety, GLP-1 and nutritional benefits of Fibersol can easily be added to GLP-1 companion products
I know how you feel, worrying about what you should start doing or where to even begin
Jenssen H, Hamill P, Hancock REW
Being a treatment for obesity isnt the only discovery about these drugs that have been made since theyve come onto the market